Bioceres CEO faces shareholder motion over asset transfers

Shareholders of Argentine entity Bioceres S.A. will vote on February 25 on a corporate liability action against CEO Federico Trucco and former director Manuel Alberto Sobrado. The motion accuses management of stripping the Argentine operating firm of its core technology assets to benefit foreign entities, including Nasdaq-listed Bioceres Crop Solutions Corp. and Moolec Science.

If approved under Article 276 of Argentina's General Companies Law, the vote would trigger the immediate removal of Trucco from his posts at Bioceres S.A. The measure would also mandate a lawsuit within three months to seek compensation from the personal assets of the accused executives.

The conflict follows financial distress at the Argentine company, which filed for voluntary reorganization at the end of December to restructure $36 million in debt after missing $5 million in commercial paper payments in mid-2025. Total liabilities affecting local bondholders and suppliers are estimated at $58 million, resulting in court freezes on company bank accounts.

Claimants argue that valuable assets, including HB4 seed patents and molecular agriculture technology, were shifted abroad during a mid-2025 corporate reorganization, leaving the Argentine unit burdened with debt. The dispute also involves majority holding shareholder Juan Sartori. In response, Bioceres maintains that previous shareholder assemblies approved all corporate transactions and that investors had the option to swap shares for Moolec equity.